Lb Pharmaceuticals (LBRX) Interest & Investment Income (2024 - 2026)
Lb Pharmaceuticals' quarterly Interest & Investment Income came in at $2.8 million in Q1 2026, up 1107.63% year-on-year from $236000.0 in Q1 2025, and up 1.79% quarter-over-quarter from $2.8 million in Q4 2025.
Lb Pharmaceuticals has reported Interest & Investment Income for 3 years, with the latest figure at $2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 1107.63% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (changed N/A YoY), and the FY2025 full-year result was $3.9 million, up 127.77% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.8 million, up from $2.8 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.8 million in Q1 2026, with the low at $236000.0 in Q1 2025.
- Average Interest & Investment Income over 3 years is $1.2 million, with a median of $545500.0 recorded in 2024.
- Year-over-year, Interest & Investment Income surged 84.11% in 2025 and jumped 1107.63% in 2026.
- Tracing LBRX's Interest & Investment Income over 3 years: stood at $298000.0 in 2024, then soared by 839.6% to $2.8 million in 2025, then rose by 1.79% to $2.8 million in 2026.
- The last three Interest & Investment Income figures came in at $2.8 million (Q1 2026), $2.8 million (Q4 2025), and $707000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | 2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.85 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 707,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Sep 30, 2024 | 384,000.00 |